Sir/ Ma''am, This is in reference to the subject matter wherein we wish to inform that the 12th (Twelfth) meeting of CoC of the company was duly convened and conducted on Thursday, 29th ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cian Healthcare Ltd informed BSE that its 12th Committee of Creditors (CoC) meeting was held on May 29, 2025, mainly to discuss the delay in submitting audited financial results for the half-year and year ended March 31, 2025. The company could not meet the 60-day SEBI deadline because it is itself undergoing Corporate Insolvency Resolution Process (CIRP) and its wholly-owned subsidiary, Dr. Smiths Biotech Pvt Ltd, has also been admitted into CIRP by the NCLT. The insolvency proceedings have restricted access to records, suspended the subsidiary's board, and made it impossible to finalise consolidated accounts. The Resolution Professional said audited results will be shared once the data is compiled and the subsidiary's first CoC meeting concludes.
This is a deeply negative signal for shareholders — the company and its key subsidiary are both in formal insolvency, annual results are delayed, and existing equity holders face high risk of dilution or near-total loss depending on how the resolution plan plays out. Expect continued stock-price weakness and heightened volatility until the CIRP is resolved.